Roy H Perlis Selected Research

Mental Disorders (Mental Disorder)

1/2022	A bidirectional competitive interaction between circHomer1 and Homer1b within the orbitofrontal cortex regulates reversal learning.
11/2020	A psychiatric disease-related circular RNA controls synaptic gene expression and cognition.
1/2019	Peripheral and central levels of kynurenic acid in bipolar disorder subjects and healthy controls.
12/2010	L-type calcium channels and psychiatric disorders: A brief review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Roy H Perlis Research Topics

Disease

41	Bipolar Disorder (Manic Depressive Psychosis) 01/2021 - 07/2002
38	Major Depressive Disorder (Major Depressive Disorders) 01/2022 - 10/2002
13	Schizophrenia (Dementia Praecox) 11/2020 - 12/2004
11	Mania (Manias) 01/2021 - 11/2003
4	Mental Disorders (Mental Disorder) 01/2022 - 12/2010
4	Depressive Disorder (Melancholia) 01/2022 - 01/2010
4	Mood Disorders (Mood Disorder) 01/2021 - 09/2009
4	Psychotic Disorders (Schizoaffective Disorder) 01/2019 - 08/2012
4	Weight Gain 08/2014 - 12/2004
3	COVID-19 01/2021 - 10/2020
3	Alcoholism (Alcohol Abuse) 03/2016 - 03/2010
3	Treatment-Resistant Depressive Disorder 06/2012 - 05/2004
3	Stroke (Strokes) 01/2012 - 12/2009
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2019 - 04/2006
2	Brain Diseases (Brain Disorder) 01/2019 - 01/2014
2	Acoustic Neuroma (Acoustic Neurinoma) 11/2018 - 01/2018
2	Cardiac Arrhythmias (Arrythmia) 01/2013 - 12/2010
2	Substance-Related Disorders (Drug Abuse) 12/2010 - 10/2008
1	Rupture 01/2022
1	Delirium 07/2021
1	Glioma (Gliomas) 01/2021
1	Neurobehavioral Manifestations 01/2020
1	Cognitive Dysfunction 01/2019
1	Neurilemmoma (Schwannoma) 01/2018
1	Meningioma (Meningiomas) 01/2018
1	Neoplasms (Cancer) 01/2018
1	Renal Insufficiency (Renal Failure) 03/2016
1	Autistic Disorder (Autism) 01/2016

Drug/Important Bio-Agent (IBA)

35	Antidepressive Agents (Antidepressants)IBA 01/2022 - 11/2003
13	LithiumIBA 01/2021 - 07/2002
9	Pharmaceutical PreparationsIBA 01/2019 - 02/2006
7	Antipsychotic Agents (Antipsychotics)IBA 01/2019 - 12/2003
7	Fluoxetine (Prozac)FDA LinkGeneric 06/2012 - 10/2002
6	Citalopram FDA LinkGeneric 03/2016 - 06/2007
5	Olanzapine (Zyprexa)FDA Link 06/2012 - 12/2004
4	Anticonvulsants (Antiepileptic Drugs)IBA 08/2012 - 12/2003
4	Duloxetine Hydrochloride (Cymbalta)FDA Link 10/2011 - 01/2008
3	Biological ProductsIBA 01/2021 - 01/2018
3	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2013 - 08/2005
3	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 10/2011 - 05/2009
3	DNA (Deoxyribonucleic Acid)IBA 11/2009 - 06/2007
2	Circular RNAIBA 01/2022 - 11/2020
2	CytokinesIBA 01/2021 - 10/2020
2	Histone Deacetylases (Histone Deacetylase)IBA 01/2020 - 01/2019
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2019 - 07/2010
2	Mifepristone (RU 486)FDA Link 11/2018 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 03/2016 - 03/2016
2	Bupropion (Wellbutrin)FDA LinkGeneric 03/2016 - 08/2014
2	Nortriptyline (Aventyl)FDA LinkGeneric 08/2014 - 12/2012
2	L-Type Calcium Channels (Dihydropyridine Receptor)IBA 03/2014 - 12/2010
2	olanzapine-fluoxetine combination (Symbyax)FDA Link 06/2012 - 05/2006
2	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 01/2012 - 11/2003
2	Calcium Channels (Calcium Channel)IBA 12/2010 - 01/2010
1	RNA IsoformsIBA 01/2022
1	Cholinergic Antagonists (Anticholinergics)IBA 07/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	FurinIBA 01/2021
1	TIE-2 Receptor (Receptor, TIE 2)IBA 01/2021
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2021
1	PhosphotyrosineIBA 01/2021
1	Cadherins (E-Cadherin)IBA 01/2021
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2021
1	Homer Scaffolding Proteins (Homer 1)IBA 11/2020
1	Messenger RNA (mRNA)IBA 11/2020
1	Adenosine Triphosphate (ATP)IBA 01/2020
1	Protons (Proton)IBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Methylphenidate (Ritalin)FDA LinkGeneric 01/2019
1	Amphetamine (Amfetamine)FDA LinkGeneric 01/2019
1	Complement System Proteins (Complement)IBA 01/2019
1	Complement C4 (Complement Component 4)IBA 01/2019
1	Docosahexaenoic AcidsIBA 01/2019
1	EnzymesIBA 01/2019
1	gamma-Aminobutyric Acid (GABA)IBA 01/2019
1	Kynurenic Acid (Kynurenate)IBA 01/2019
1	KynurenineIBA 01/2019
1	MetalsIBA 01/2019
1	martinostatIBA 01/2019
1	Minocycline (Cyclops)FDA LinkGeneric 01/2019
1	Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric 01/2019
1	Phosphotransferases (Kinase)IBA 01/2019
1	Protein Kinase CIBA 01/2019
1	Tryptophan (L-Tryptophan)FDA Link 01/2019
1	Eicosapentaenoic AcidIBA 01/2019
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2019
1	N-Methylaspartate (NMDA)IBA 01/2019
1	antineoplaston A10 (A 10)IBA 05/2018
1	MicroRNAs (MicroRNA)IBA 01/2018
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2018
1	Progesterone FDA LinkGeneric 01/2018
1	Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric 03/2016
1	Topiramate (Topamax)FDA LinkGeneric 03/2016
1	Sertraline (Zoloft)FDA LinkGeneric 03/2016

Therapy/Procedure

8	Therapeutics 01/2021 - 07/2002
3	Drug Therapy (Chemotherapy) 01/2021 - 07/2002
2	Precision Medicine 01/2021 - 09/2009
1	Induced Labor 01/2022
1	Subacute Care 01/2021
1	Length of Stay 01/2020
1	Microelectrodes 01/2020